CLASS II Drug recall · Reported 28 May 2014 · FDA Enforcement Report

Bystolic (nebivolol), 20 mg/tablet recalled by Forest Pharmaceuticals

Forest Pharmaceuticals is recalling Bystolic (nebivolol), 20 mg/tablet per, distributed nationwide in the US. The recall was initiated on 12 May 2014 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: A287945, Exp: 08/2015
NDC0456-1402, 0456-1405, 0456-1410, 0456-1420
UPC0304561405909, 0304561402304, 0304561420902, 0304561410903
Quantity recalled21,875 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1348-2014
FDA event ID
68246
Recalling firm
Forest Pharmaceuticals, Earth City, MO
Manufacturer
Allergan, Inc.
Classification
Class II
Status
Terminated
Recall initiated
12 May 2014
FDA classified
22 May 2014
Reported
28 May 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

12 May 2014Recall initiated by company
22 May 2014Classified by FDA+10 days
28 May 2014Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Bystolic (nebivolol), 20 mg/tablet, 30 tablets per bottle, Rx only, Licensed from Mylan Laboratories Inc., Under license from Janssen Pharmaceutica NV, Belgium, Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, NDC 0456-1420-30

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications: One lot of product is being voluntarily recalled because dissolution test results failed to meet specification throughout the product's shelf life.

Which lots are affected?

Lot: A287945, Exp: 08/2015

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Forest Pharmaceuticals

All 6

Other Nebivolol recalls

All 4